Clinical Insights in VTE: Prophylaxis of Acutely Ill Medical Patients, the Treatment of DVT/PE, and the Reduction in the Risk of Recurrent DVT/PE
About this LIVE Event
This program will discuss venous thromboembolism (VTE) prophylaxis for acutely ill medical patients, as well as treatment options for patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and how these treatment options may reduce the risk of recurrent thrombotic events.
COMPLIANCE POLICY
In adherence with PhRMA guidelines, spouses or other guests are not permitted to attend company-sponsored programs.
For all attendees, please be advised that information such as your name and the value and purpose of any educational item, meal, or other items of value you receive may be publicly disclosed. If you are licensed in any state or other jurisdiction, or are an employee or contractor of any organisation or governmental entity, that limits or prohibits meals from pharmaceutical companies, please identify yourself so that you (and we) are able to comply with such requirements.
Please note that the company prohibits the offering of gifts, gratuities, or meals to federal government employees/officials. Thank you for your cooperation.
This promotional educational activity is not accredited. The program content is developed by Janssen Pharmaceuticals, Inc. Speakers present on behalf of the company and are required to present information in compliance with FDA requirements for communications about its medicines.
The personal information you provide may be used to contact you about your request to attend the Janssen Pharmaceuticals, Inc., educational program using your preferred method of communication as indicated by you. This information may be shared with Janssen Pharmaceuticals, Inc., its affiliates, and a third party for the sole purpose of completing your registration for this program and as required by law.